Literature DB >> 16439120

Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists.

Bernd Büttelmann1, Jens-Uwe Peters, Simona Ceccarelli, Sabine Kolczewski, Eric Vieira, Eric P Prinssen, Will Spooren, Franz Schuler, Jörg Huwyler, Richard H P Porter, Georg Jaeschke.   

Abstract

Optimisation of affinity, chemical stability, metabolic stability and solubility led from a chemically labile HTS hit 1 to mGlu5 receptor antagonists (24-26) with high affinity for the allosteric MPEP binding site, improved microsomal metabolic stability and anxiolytic-like activity in vivo as assessed by the Vogel conflict drinking test.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439120     DOI: 10.1016/j.bmcl.2005.12.088

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists.

Authors:  Santosh S Kulkarni; Amy Hauck Newman
Journal:  Bioorg Med Chem Lett       Date:  2007-03-24       Impact factor: 2.823

2.  Preparation of a Series of 5-Methyl-3-(substituted)-[1,2,4]triazines.

Authors:  Moses G Gichinga; Jeremy P Olson; Elizabeth Butala; Brian P Gilmour; Hernán H Navarro; F Ivy Carroll
Journal:  Tetrahedron Lett       Date:  2011-06-29       Impact factor: 2.415

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.